Suppr超能文献

相似文献

2
Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.
J Hepatol. 2017 Nov;67(5):1018-1025. doi: 10.1016/j.jhep.2017.06.014. Epub 2017 Jun 22.
4
5
6
Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice.
J Hepatol. 2014 Nov;61(5):1029-37. doi: 10.1016/j.jhep.2014.06.007. Epub 2014 Jun 16.
7
Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury.
Liver Int. 2006 Apr;26(3):346-51. doi: 10.1111/j.1478-3231.2005.01216.x.
8
Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.
J Leukoc Biol. 2015 Jan;97(1):161-9. doi: 10.1189/jlb.3A0614-280R. Epub 2014 Nov 14.
9
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
J Clin Invest. 2015 Jun;125(6):2399-412. doi: 10.1172/JCI80467. Epub 2015 May 11.
10
Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response.
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):469-477. doi: 10.1016/j.hbpd.2021.07.002. Epub 2021 Jul 24.

引用本文的文献

1
Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease.
Cell Mol Immunol. 2025 May 21. doi: 10.1038/s41423-025-01291-w.
5
Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease.
Int J Mol Sci. 2023 Feb 13;24(4):3735. doi: 10.3390/ijms24043735.
6
Emerging Pharmacotherapies in Alcohol-Associated Hepatitis.
J Clin Exp Hepatol. 2023 Jan-Feb;13(1):116-126. doi: 10.1016/j.jceh.2022.06.012. Epub 2022 Jul 3.
7
Pathogenesis of Alcohol-Associated Liver Disease.
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1492-1513. doi: 10.1016/j.jceh.2022.05.004. Epub 2022 May 31.
8
Role of the chemokine system in liver fibrosis: a narrative review.
Dig Med Res. 2022 Jun;5. doi: 10.21037/dmr-21-87. Epub 2022 Jun 30.
9
Exercise inhibits JNK pathway activation and lipotoxicity macrophage migration inhibitory factor in nonalcoholic fatty liver disease.
Front Endocrinol (Lausanne). 2022 Sep 6;13:961231. doi: 10.3389/fendo.2022.961231. eCollection 2022.
10
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.
J Transl Med. 2022 Jul 16;20(1):320. doi: 10.1186/s12967-022-03528-y.

本文引用的文献

1
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1310-21. doi: 10.1152/ajpgi.00365.2011. Epub 2012 Mar 22.
2
Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.
Cytokine. 2012 Jan;57(1):150-7. doi: 10.1016/j.cyto.2011.11.009. Epub 2011 Dec 3.
3
Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.
Mol Med. 2012 Mar 27;18(1):215-23. doi: 10.2119/molmed.2011.00094.
6
Alcoholic liver disease: pathogenesis and new targets for therapy.
Nat Rev Gastroenterol Hepatol. 2011 Aug 9;8(9):491-501. doi: 10.1038/nrgastro.2011.134.
7
Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation.
Science. 2011 Jun 10;332(6035):1284-8. doi: 10.1126/science.1204351. Epub 2011 May 12.
9
Innate immunity in alcoholic liver disease.
Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G516-25. doi: 10.1152/ajpgi.00537.2010. Epub 2011 Jan 20.
10
Antigen-presenting cell function in the tolerogenic liver environment.
Nat Rev Immunol. 2010 Nov;10(11):753-66. doi: 10.1038/nri2858.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验